Back to Search Start Over

Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell Function

Authors :
Puja Patel
Claire E. Repellin
Lidia Sambucetti
Haritha K. Duggireddy Lakshmireddy
Harold S. Javitz
Javier F. Alcudia
Lucia Beviglia
Priya Ganesan
Parijat Bhatnagar
Source :
Adv Biosyst
Publication Year :
2019

Abstract

A set of genetically engineered isogenic cell lines is developed to express either folate receptor alpha or mesothelin, and a control cell line negative for both antigens. These cell lines also express fluorescent and bioluminescent reporter transgenes. The cell lines are used to authenticate specificity and function of a T-cell biofactory, a living vector that is developed to express proportionate amounts of engineered proteins upon engaging with disease cells through their specific antigenic biomarkers. The engineered cell lines are also used to assess the cytolytic function and specificity of primary T cells engineered with chimeric antigen receptors; and the specificity of monoclonal antibodies. The strategy described can be used to generate other cell lines to present different disease-specific biomarkers for use as quality control tools.

Details

ISSN :
23667478
Volume :
4
Issue :
1
Database :
OpenAIRE
Journal :
Advanced biosystems
Accession number :
edsair.doi.dedup.....2951b12087127a8b4ac6994774b2d3ab